ClinicalTrials.gg
CompletedNCT07152314Updated Sep 11, 2026

Digital Quantification of Dental Plaque Based on Intraoral Scanner Images

An observational study in Dental Plaque (Diagnosis), Dental Plaque Imaging Methods and Dental Plaque, sponsored by University of Guarulhos. Completed at 1 site in Brazil. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by University of Guarulhos · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
20
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Dental Plaque with a site in Brazil — none open to participants now, none under way, none of them phase 3. Dental Plaque · Brazil.

Started
2025
with 1 other
Observational
Only one
of the 19
Registered
19th of 19
by date
Lead sponsor
2 of 19
University of Guarulhos

Among the 19 studies in Dental Plaque with a site in Brazil, this one is one of 2 that started in 2025, is the only observational one, and was the 19th registered.

Dental Plaque

354 studies on the registry are indexed under Dental Plaque; 61 are open to participants now.

Browse Dental Plaque studies →

Open to participants now

None of the 19 studies in Dental Plaque with a site in Brazil is open now. The open studies under Dental Plaque, anywhere →

Who these studies take

Of the 36 Dental Plaque studies recruiting now, 10 (28%) set no upper age limit and 21 (58%) stop at 75 or younger; 14 take children under 18; 22 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 19 studies in Dental Plaque with a site in Brazil as a file.
02

Study summary

This diagnostic validation study aims to develop and validate a digital method for dental biofilm quantification using three-dimensional images obtained by an intraoral scanner. Twenty participants will undergo intraoral scanning at three time points: before and after plaque disclosure, and after supervised toothbrushing. The digital method's accuracy will be compared with traditional clinical assessment methods (Turesky Plaque Index).

Read the detailed description

A prospective, evaluator-blinded clinical study including 20 participants (18-65 years) with at least 20 natural teeth and a visible plaque index >20%. Participants will be evaluated at three time points in a single session using TRIOS 4 intraoral scanner. Digital analysis will be performed using Geomagic Control X software to calculate the percentage of surface area covered by plaque. The study includes standardized intraoral photographs and supervised toothbrushing procedures. This digital method aims to provide a more objective and precise assessment of dental biofilm, overcoming limitations of conventional visual assessment methods.

03

Conditions studied

  • Dental Plaque (Diagnosis)
  • Dental Plaque Imaging Methods
  • Dental Plaque
  • Gingivitis
  • Periodontal Disease

Keywords

  • Dental Biofilm
  • Intraoral Scanner
  • Preventive Dentistry
  • Plaque quantification
  • Digital Diagnosis
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Recruitment will be carried out through different communication channels, including informative posters distributed in the dental clinics of UnG, digital dissemination on the university's official website and its institutional social networks, direct invitation to patients who are on the waiting list of the periodontics clinic, and dissemination by the professors of the undergraduate and graduate clinics. All promotional materials will clearly state the inclusion and exclusion criteria, as well as provide contact information for scheduling, initial screening, and the ethics committee approval number. All participants will attend the Center for Clinical Studies of Univeritas UnG.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Presence of at least 20 natural teeth
  • Visible plaque index > 20% at initial assessment
  • Age between 18 and 65 years
  • Both sexes eligible

Exclusion criteria

Exclusion Criteria:

  • Use of fixed orthodontic appliances
  • Presence of extensive restorations or fixed dentures on the anterior teeth
  • Systemic conditions that interfere with the formation of dental biofilm
  • Use of medications that alter salivary flow
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testDigital plaque quantification using intraoral scanner

    Participants will undergo three-dimensional intraoral scanning at three time points during a single session: initial scanning (T0), after biofilm disclosure with plaque disclosing solution (T1), and after supervised toothbrushing (T2).

06

What researchers measure

Primary outcomes

  1. Correlation between digital 3D intraoral scans and traditional plaque assessment methods

    Correlation between the percentage of dental surface area covered by biofilm quantified by the digital method (intraoral scanner) and the plaque index obtained by the traditional clinical method (Quigley-Hein Plaque Index modified by Turesky)

    Time frame: Single session (approximately 1.5-2 hours)

Secondary outcomes

  1. Correlation between digital 2D images and traditional plaque assessment methods

    Correlation between the percentage of dental surface area covered by biofilm quantified by intraoral photographs with different filters and the plaque index obtained by the traditional clinical method (Quigley-Hein Plaque Index modified by Turesky)

    Time frame: Single session (approximately 1.5-2 hours)

  2. Fluorescence imaging capabilities

    Detection sensitivity for plaque, correlation with clinical findings, and reproducibility of fluorescence measurements.

    Time frame: Single session (approximately 1.5-2 hours)

  3. Plaque volume changes analysis

    Ability of the digital method to detect changes in the amount of biofilm, evaluated by the percentage difference in area covered between T0 (initial), T1 (after disclosure) and T2 (after professional brushing).

    Time frame: Single session (approximately 1.5-2 hours)

  4. Plaque thickness changes analysis

    Ability of the digital method to detect changes in the amount of biofilm, evaluated by the color map difference in area covered between T0 (initial), T1 (after disclosure), and T2 (after professional brushing), and correlating those with other features, such as disclosing agent color and fluorescence.

    Time frame: Single session (Approximately 1.5-2 hours)

07

Study locations

1 site
  • University of Guarulhos
    Guarulhos, São Paulo 07.023-070, Brazil
08

References and documents

Publications

  • Del Rey YC, Rikvold PD, Johnsen KK, Schlafer S. A fast and reliable method for semi-automated planimetric quantification of dental plaque in clinical trials. J Clin Periodontol. 2023 Mar;50(3):331-338. doi: 10.1111/jcpe.13745. Epub 2022 Nov 28. PubMed 36345833 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — IPD will be available for sharing based on a reasonable request

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2025 to primary completion in Oct 2025, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2025
First posted
Sep 3, 2025
StartActual
Sep 19, 2025
Primary completionActual
Oct 4, 2025
CompletionActual
Oct 4, 2025
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07152314
Lead sponsor
University of Guarulhos
Collaborators
Colgate Palmolive
Responsible party
MOHAMED AHMED HASSAN (Professor, University of Guarulhos) — Principal investigator
First posted
Sep 3, 2025
Start date
Sep 19, 2025
Primary completion
Oct 4, 2025
Completion
Oct 4, 2025
Last update
Sep 11, 2026

Study contacts

Mohamed A Hassan, PhD
principal investigator · University of Guarulhos

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion